Biotech entity

Shanghai Haohai Biological Technology Co., Ltd

Company

All 1 tracked stories fall under one category: pharma. Bloomage Biotechnology is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. The tracked stories average 2 original sources each. Shanghai Haohai Biological Technology Co., Ltd appears in 1 tracked Biotech story from March 21, 2026.

Last mentioned: Mar 21, 2026

Entity pulse

Recent coverage · Shanghai Haohai Biological Technology Co., Ltd

1 story
5 avg impact
0% positive
0% negative
  • 100% neutral

Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.

What the coverage shows about Shanghai Haohai Biological Technology Co., Ltd

All 1 tracked stories fall under one category: pharma. Bloomage Biotechnology is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. The tracked stories average 2 original sources each. Shanghai Haohai Biological Technology Co., Ltd appears in 1 tracked Biotech story from March 21, 2026.

Stories tracked
1
Sources per story
2

Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 12 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.

Coverage cohort

Appears alongside

Other entities that clear the same relevance threshold in stories also covering Shanghai Haohai Biological Technology Co., Ltd. Shared-story counts are live from our verified record — not editorial picks.

Timeline

  1. Annual Results Announcement

    Official report confirms a retreat in full-year net income compared to the previous fiscal year.

  2. VBP Participation

    Company participates in multi-province centralized procurement for intraocular lenses, securing volume at lower price points.

  3. Aesthetics Expansion

    Haohai launches new line of high-end dermal fillers to compete in the premium aesthetics market.

Stories mentioning Shanghai Haohai Biological Technology Co., Ltd 1

Pharma Neutral

Haohai Biological Reports Full-Year Income Retreat Amid VBP Pressures

Shanghai Haohai Biological Technology Co., Ltd. has reported a decline in full-year income for the 2025 fiscal year, driven by margin compression in its core ophthalmology and orthopedic segments. The retreat highlights the ongoing challenges of China's volume-based procurement (VBP) policies and intensifying competition in the medical aesthetics market.

2 sources

Shanghai Haohai Biological Technology Co., Ltd is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.

See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.